Jacobs Levy Equity Management’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,470
| Closed | -$235K | – | 1106 |
|
|
2019
Q3 | $235K | Sell |
3,470
-64,258
| -95% | -$4.41M | ﹤0.01% | 815 |
|
|
2019
Q2 | $3.94M | Sell |
67,728
-76,409
| -53% | -$4.53M | 0.05% | 391 |
|
|
2019
Q1 | $10.1M | Buy |
144,137
+72,270
| +101% | +$5.36M | 0.15% | 182 |
|
|
2018
Q4 | $4.63M | Sell |
71,867
-73,626
| -51% | -$5.16M | 0.08% | 279 |
|
|
2018
Q3 | $10.2M | Buy |
145,493
+23,533
| +19% | +$1.38M | 0.14% | 178 |
|
|
2018
Q2 | $6.15M | Sell |
121,960
-290
| -0.2% | -$11.5K | 0.1% | 254 |
|
|
2018
Q1 | $3.83M | Buy |
122,250
+10,160
| +9% | +$337K | 0.06% | 333 |
|
|
2017
Q4 | $3.83M | Sell |
112,090
-14,382
| -11% | -$459K | 0.07% | 321 |
|
|
2017
Q3 | $4.06M | Buy |
126,472
+23,492
| +23% | +$741K | 0.08% | 286 |
|
|
2017
Q2 | $3.35M | Sell |
102,980
-2,450
| -2% | -$77.6K | 0.07% | 313 |
|
|
2017
Q1 | $3.32M | Buy |
105,430
+760
| +0.7% | +$22.5K | 0.07% | 320 |
|
|
2016
Q4 | $3.08M | Buy |
104,670
+40,900
| +64% | +$1.25M | 0.06% | 335 |
|
|
2016
Q3 | $1.84M | Buy |
63,770
+20,367
| +47% | +$567K | 0.03% | 433 |
|
|
2016
Q2 | $1.12M | Sell |
43,403
-5,500
| -11% | -$146K | 0.02% | 557 |
|
|
2016
Q1 | $1.21M | Sell |
48,903
-20,980
| -30% | -$576K | 0.03% | 525 |
|
|
2015
Q4 | $2.46M | Buy |
69,883
+2,410
| +4% | +$64.5K | 0.05% | 305 |
|
|
2015
Q3 | $1.43M | Buy |
67,473
+16,780
| +33% | +$432K | 0.03% | 422 |
|
|
2015
Q2 | $1.41M | Buy |
50,693
+11,180
| +28% | +$315K | 0.03% | 422 |
|
|
2015
Q1 | $1.21M | Sell |
39,513
-3,380
| -8% | -$107K | 0.02% | 441 |
|
|
2014
Q4 | $1.37M | Sell |
42,893
-910
| -2% | -$29.6K | 0.02% | 445 |
|
|
2014
Q3 | $1.24M | Buy |
+43,803
| New | +$1.22M | 0.02% | 460 |
|
|
2014
Q1 | – | Sell |
-8,280
| Closed | -$242K | – | 1056 |
|
|
2013
Q4 | $242K | Buy |
+8,280
| New | +$263K | ﹤0.01% | 844 |
|
Jacobs Levy Equity Management's GHDX Position: Q4 2019 in Review
Jacobs Levy Equity Management sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 3,470 shares — an estimated $235K sold.
Jacobs Levy Equity Management first reported a position in GHDX in Q4 2013 and held it in 22 quarters. The position peaked at $10.2M in Q3 2018. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Jacobs Levy Equity Management reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Jacobs Levy Equity Management sold 3,470 Genomic Health, Inc. shares in Q4 2019, an estimated $235K.
- Jacobs Levy Equity Management first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 22 quarters.
- Jacobs Levy Equity Management's Genomic Health, Inc. position peaked at $10.2M in Q3 2018.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.